MaxCyte Affirms FY2026 Sales Guidance
MaxCyte affirms FY2026 sales outlook of $30.000M-$32.000M
MaxCyte (NASDAQ: MXCT ) affirms FY2026 sales outlook from $30.000 million-$32.000 million to $30.000 million-$32.000 million vs $31.082 million estimate.
MaxCyte affirms FY2026 sales outlook of $30.000M-$32.000M
MaxCyte (NASDAQ: MXCT ) affirms FY2026 sales outlook from $30.000 million-$32.000 million to $30.000 million-$32.000 million vs $31.082 million estimate.